Federally qualified health centers pay an important role in providing primary care and preventive services for patients who may have trouble accessing this care because of their insurance status, explained M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine.
Federally qualified health centers pay an important role in providing primary care and preventive services for patients who may have trouble accessing this care because of their insurance status, explained M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine.
Transcript
What role do federally qualified health centers play, and why are they important for uninsured and underinsured patients?
Federally qualified health centers, it’s a program that’s been around since the Johnson administration, so they’ve been around for a while now, and they always play an important role in safety net provision for primary care as well as for other services, mental health services, dental services, and various different special programs. Particularly for the uninsured, one of the grant stipulations, [Health Resources and Services Administration], is that they provide care regardless of a patient’s ability to pay and have a sliding-fee scale based on the person’s income and also take Medicaid, that’s an important qualification, too.
So, throughout these decades that the health center program has been around, they’ve served these places providing primary care and preventative services that may not be accessible for somebody without insurance. It’s a very important role and additionally, they are intentionally situated in medically underserved areas so that could be an urban area or rural area or somewhere with a special needs population so people that are already marginalized by the insurance health system because of their insurance status or because of other factors. They are experiencing homelessness, or they are a migrant farm worker, or other qualifying characteristics, they are going to receive more appropriate services in a way that are affordable and also accessible to them otherwise.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More